{"id":62353,"date":"2025-12-13T16:06:11","date_gmt":"2025-12-13T15:06:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/"},"modified":"2025-12-13T16:06:11","modified_gmt":"2025-12-13T15:06:11","slug":"neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/","title":{"rendered":"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Precision biomarker company\u2019s Scientific Advisory Board includes multiple Nobel Prize winners and the creators of current gold standard in Parkinson\u2019s disease progression<\/i>\n<\/p>\n<p>CAMBRIDGE, Mass., AUSTIN, Texas &amp; TEL AVIV, Israel&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fneuralight.ai%2F&amp;esheet=54375230&amp;newsitemid=20251212322467&amp;lan=en-US&amp;anchor=NeuraLight&amp;index=1&amp;md5=14142a733d90029dc159a395ce1e89e2\" rel=\"nofollow\" shape=\"rect\">NeuraLight<\/a>, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas S\u00fcdhof, a Nobel Prize-winning neuroscientist and one of the world\u2019s leading Alzheimer\u2019s disease researchers, has been named Scientific Co-founder of the company and joined its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fneuralight.ai%2Fteam%2F&amp;esheet=54375230&amp;newsitemid=20251212322467&amp;lan=en-US&amp;anchor=Scientific+Advisory+Board&amp;index=2&amp;md5=ff9de0c1f26248eb57e78f16c1299861\" rel=\"nofollow\" shape=\"rect\">Scientific Advisory Board<\/a>. This follows <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fneuralight.ai%2Frenowned-parkinsons-expert-prof-olivier-rascol-appointed-to-lead-neuralights-scientific-advisory-board%2F&amp;esheet=54375230&amp;newsitemid=20251212322467&amp;lan=en-US&amp;anchor=the+announcement&amp;index=3&amp;md5=9b486e00e5488c97e7950ae0f465bc32\" rel=\"nofollow\" shape=\"rect\">the announcement<\/a> that world-recognized neurologist Prof. Olivier Rascol, a co-creator of the current gold standard for measuring Parkinson\u2019s disease progression (MDS-UPDRS), will head the board.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/5\/nl-light-logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/5\/nl-light-logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/21\/nl-light-logo.jpg\"><\/a><\/p>\n<p>\nThe unparalleled collective clinical expertise of the board will strengthen NeuraLight\u2019s validation-first strategy, which has already produced movement-based progression measures with 10x more sensitivity than MDS-UPDRS. Each member will help to advance NeuraLight\u2019s clinical validation roadmap, support pharmaceutical trial integration and guide the company\u2019s expansion of precision progression measurement at scale. The full board is composed of:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Prof. Thomas S\u00fcdhof<\/b> was a 2013 Nobel laureate for his work on the mechanism of synaptic transmission, and currently heads the S\u00fcdhof Lab at Stanford University. He oversees the scientific foundations of NeuraLight\u2019s biomarkers and supports the continued advancement of its work in Alzheimer\u2019s disease and other neurological indications. Having advised NeuraLight since its early stages of scientific development, Prof. S\u00fcdhof now serves as Scientific Co-founder and a member of the Scientific Advisory Board.\n<\/li>\n<li>\n<b>Prof. Olivier Rascol<\/b> brings more than 30 years of leadership in Parkinson\u2019s disease clinical research and deep expertise in motor progression, disease modification and clinical trial design. His work has helped shape how progression is measured and how treatments are evaluated in neurodegenerative diseases. A professor of clinical pharmacology at Toulouse University Hospital, he led promising recent <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpharmaphorum.com%2Fnews%2Ftrial-finds-benefit-glp-1-agonist-parkinsons&amp;esheet=54375230&amp;newsitemid=20251212322467&amp;lan=en-US&amp;anchor=research+on+the+use+of+GLP-1&amp;index=4&amp;md5=dea18f8c4aeb7d523845074a3dd05e34\" rel=\"nofollow\" shape=\"rect\">research on the use of GLP-1<\/a> to treat Parkinson\u2019s disease. At NeuraLight, Prof. Rascol will guide scientific strategy and help expand the clinical utility of the platform as it continues scaling its precision biomarkers across therapeutic areas.\n<\/li>\n<li>\n<b>Prof. Alvin Roth<\/b> has worked widely on market design, including in health care, for which he won the 2012 Nobel Prize in Economics. He is a professor of economics at Stanford University. He is supporting NeuraLight with market design, helps structure value-based partnerships with healthcare stakeholders and advises on our overall ecosystem strategy.\n<\/li>\n<\/ul>\n<p>\n\u201cWe are thrilled and honored to welcome some of the world\u2019s most recognized and impactful scientists to the board. They will be invaluable in advancing NeuraLight\u2019s clinical validation strategy and pharmaceutical partnerships,\u201d said Edmund Ben-Ami, NeuraLight\u2019s CEO and co-founder. \u201cWe see this as further confirmation that our platform can truly transform the way disease progression is measured.\u201d\n<\/p>\n<p>\nNeuraLight harnessed a century\u2019s worth of research on the brain-eye movement connection to build a 10-minute assessment, conducted on a standard tablet, that delivers biomarkers with the ability to detect disease changes that traditional methods cannot. The platform is currently deployed in clinical partnerships across the globe, spanning over 1,200 patients with Parkinson\u2019s, ALS, MS and Huntington\u2019s disease, as well as in multiple commercial pharmaceutical trials.\n<\/p>\n<p>\n\u201cI have been impressed by the quality of NeuraLight\u2019s validation data,\u201d said Prof. Rascol. \u201cClinical scales are useful but often noisy, and imaging is costly and complex. That\u2019s why I\u2019m excited by NeuraLight\u2019s eye-movement biomarkers; they provide objective, quantitative measures of disease severity and can detect subtle changes in disease progression missed by traditional clinical assessments.\u201d\n<\/p>\n<p>\nWorking closely with the board to support NeuraLight\u2019s clinical strategy are several key scientific advisors:\n<\/p>\n<p>\n<b>Prof. Cristina Sampaio<\/b>, Chief Medical Officer for the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fchdifoundation.org%2F&amp;esheet=54375230&amp;newsitemid=20251212322467&amp;lan=en-US&amp;anchor=CDHI+Foundation&amp;index=5&amp;md5=597a1015645ceab1a8e8064bf30c95b9\" rel=\"nofollow\" shape=\"rect\">CDHI Foundation<\/a> (Cure Huntington&#8217;s Disease Initiative Foundation), is one of the foremost experts on movement disorders and clinical pharmacology. She is a Professor of Clinical Pharmacology and Therapeutics at the University of Lisbon.\n<\/p>\n<p>\n<b>Prof. Fred Lublin<\/b>, a widely known authority on the treatment of MS, serves as director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center in New York.\n<\/p>\n<p>\n<b>Prof. Chris Goetz<\/b>, co-creator of the MDS-UPDRS, is a leading expert in movement disorder pharmacology and rating-scale development. He is a professor in the Department of Neurological Sciences and Pharmacology, and serves as director of the Movement Disorders Program, at Rush University Medical Center in Chicago.\n<\/p>\n<p>\n<b>About NeuraLight<br \/>\n<br \/><\/b>NeuraLight is a healthtech company transforming neurology with precision biomarkers. The NeuraLight platform addresses the core challenge of accurately monitoring neurological disease progression. Our unprecedentedly accurate biomarkers enable better targeting of underserved patient populations for existing therapies and facilitate the development of new treatments by de-risking drug trials, increasing their efficiency, and accelerating timelines. NeuraLight&#8217;s biomarkers play an essential role in multiple commercial partnerships, and are endorsed by leading neurologists, Nobel Laureates, and key research foundations. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fneuralight.ai%2F&amp;esheet=54375230&amp;newsitemid=20251212322467&amp;lan=en-US&amp;anchor=neuralight.ai.&amp;index=6&amp;md5=62b407e2ec8a593231fb5ccf6f3d6502\" rel=\"nofollow\" shape=\"rect\">neuralight.ai.<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKeren Sharon, Product Marketing Manager, <a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x69;n&#102;&#x6f;&#x40;n&#101;&#x75;&#x72;a&#108;&#x69;&#x67;h&#116;&#46;&#x61;&#x69;\" rel=\"nofollow\" shape=\"rect\">&#105;&#x6e;&#102;&#x6f;&#64;&#x6e;e&#117;&#x72;&#97;&#x6c;&#105;&#x67;h&#x74;&#46;&#97;&#x69;<\/a>.\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Precision biomarker company\u2019s Scientific Advisory Board includes multiple Nobel Prize winners and the creators of current gold standard in Parkinson\u2019s disease progression CAMBRIDGE, Mass., AUSTIN, Texas &amp; TEL AVIV, Israel&#8211;(BUSINESS WIRE)&#8211;NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas S\u00fcdhof, a Nobel Prize-winning neuroscientist and one of the world\u2019s &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62353","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Precision biomarker company\u2019s Scientific Advisory Board includes multiple Nobel Prize winners and the creators of current gold standard in Parkinson\u2019s disease progression CAMBRIDGE, Mass., AUSTIN, Texas &amp; TEL AVIV, Israel&#8211;(BUSINESS WIRE)&#8211;NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas S\u00fcdhof, a Nobel Prize-winning neuroscientist and one of the world\u2019s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-13T15:06:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology\",\"datePublished\":\"2025-12-13T15:06:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/\"},\"wordCount\":827,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251212322467\\\/en\\\/2668851\\\/22\\\/nl-light-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/\",\"name\":\"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251212322467\\\/en\\\/2668851\\\/22\\\/nl-light-logo.jpg\",\"datePublished\":\"2025-12-13T15:06:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251212322467\\\/en\\\/2668851\\\/22\\\/nl-light-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251212322467\\\/en\\\/2668851\\\/22\\\/nl-light-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/","og_locale":"en_US","og_type":"article","og_title":"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology - Pharma Trend","og_description":"Precision biomarker company\u2019s Scientific Advisory Board includes multiple Nobel Prize winners and the creators of current gold standard in Parkinson\u2019s disease progression CAMBRIDGE, Mass., AUSTIN, Texas &amp; TEL AVIV, Israel&#8211;(BUSINESS WIRE)&#8211;NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas S\u00fcdhof, a Nobel Prize-winning neuroscientist and one of the world\u2019s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-13T15:06:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology","datePublished":"2025-12-13T15:06:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/"},"wordCount":827,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/","url":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/","name":"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg","datePublished":"2025-12-13T15:06:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251212322467\/en\/2668851\/22\/nl-light-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/neuralight-reveals-the-world-class-scientific-leaders-helping-to-advance-its-transformation-of-disease-progression-measurement-in-neurology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62353"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62353\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}